الرئيسية / الفعاليات العلمية / Risk of an Excess Cancer Fatality Due to Ingestion of Uranium from Some Pharmaceuticals in Iraq

Risk of an Excess Cancer Fatality Due to Ingestion of Uranium from Some Pharmaceuticals in Iraq

Mohsen AAH1
, Al-Khayyat AN1
, Salman AY2
, Abojassim AA3
* and Hussain HH3
1
Department of Pediatrics, Ibn Hayan University, Iraq
2
Department of Computer techniques, Imam Al-Kadhum College, Iraq
3
Department of Physics, University of Kufa, Iraq

Abstract
In present work, uranium-238 was measured for (44) samples of medical drugs in Iraqi pharmacies. CR-39 detectors were used in the present study. Also, the “annual
average internal dose” (AAIED) and “risk of an excess cancer fatality per million person” (RECFPMP) due to ingestion of these radionuclides in all samples of
medical drugs were calculated. The results show that, the average of 238U concentrations in solid samples were (0.29±0.05 ppm), while the average value of (AAIED)
and RECFPMP due to ingestion of 238U in drugs samples under study has been found (0.058±0.01μSv/y) and (0.23±0.04) respectively. All results of the value of
AAIED and RECFPMP are with a world limit according to UNSCEAR and ICRP respectively. So, the intake of the studied samples of medical drugs in Iraq does
due to Uranium concentrations not lead to substantial changes in the internal effective dose. Itconcludes that, the uranium concentration in the samples under study
were not significant from a health hazard point of view.
Keywords: Cancer risk; Uranium concentrations; CR-39; Pharmaceuticals

1 (22)

شاهد أيضاً

Measurement of Rn222 gas in Juice from Iraqi markets

1Entesser Salman, 2 Ghaidaa Jaber, 3 Hayder Neama, 4 Ali Abojassim, 5 B. Almayahi 1Department …

اترك تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *